Compound: nandrolone phenylpropionate
SMILES: O=C1C=C2[C@@H]([C@@H]3[C@H]([C@H]4[C@]([C@@H](OC(=O)CCc5ccccc5)CC4)(C)CC3)CC2)CC1
InChIKey: UBWXUGDQUBIEIZ-QNTYDACNSA-N
Synonyms: nandrolone phenylpropionate, Nandrolone phenpropionate, 62-90-8, Nortestosterone phenylpropionate, Nandrolon phenylpropionate, NTPP, Norandrostenolone phenylpropionate, 19Ntpp, Norandrolone phenyl propionate, Norandrolone phenylpropionate, Nandrolone Phenylpionate, Hybolin, NSC-23162, DTXSID2023353, KF7Z9K2T3W, CHEBI:7468, DTXCID603353, Nandrolone phenpropionate (USP), Nandrolone phenpropionate [USP], NSC23162, Nerobolyl, (1S,2R,10R,11S,14S,15S)-15-methyl-5-oxotetracyclo(8.7.0.0^(2,7).0^(11,15))heptadec-6-en-14-yl 3-phenylpropanoate, (1S,2R,10R,11S,14S,15S)-15-methyl-5-oxotetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-6-en-14-yl 3-phenylpropanoate, RefChem:164520, Nortestosterone Furanpropionate, 200-551-9, Durabolin, Fenobolin, Nandrolin, Nerobolil, Nadrolone phenylpropionate, Phenobolin, Superanabolon, Strabolene, Nandrobolic, Activin, Nerobil, 19-Nortestosterone, hydrocinnamate, 19-Nortestosterone phenylpropionate, 19-Nortestosterone phenyl propionate, 19-Norandrostenolone phenylpropionate, SK 22271, 17b-hydroxyestr-4-en-3-one 17-(3-phenylpropionate), 17beta-Hydroxyestr-4-en-3-one hydrocinnamate, [(8R,9S,10R,13S,14S,17S)-13-methyl-3-oxo-2,6,7,8,9,10,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl] 3-phenylpropanoate, Anticatabolin, Estr-4-en-3-one, 17-(1-oxo-3-phenylpropoxy)-, (17b)-, 17-(1-oxo-3-phenylpropoxy)estr-4-en-3-one, 3-oxoestr-4-en-17beta-yl 3-phenylpropanoate, Nandrolone phenylpropionate (JAN), Sintabolin, Anabosan, Equibolin, Norandrol, CAS-62-90-8, Durabolin-50, NANDROLONE PHENYLPROPIONATE [JAN], UNII-KF7Z9K2T3W, Activine, UBWXUGDQUBIEIZ-QNTYDACNSA-N, Durabolin (TN), NCGC00159356-02, EINECS 200-551-9, NSC 23162, 17.beta.-Phenylpropionyloxy-4-estrene-3-one, BRN 3170861, 17-.beta.-hydroxyestr-4-en-3-one hydrocinnamate, 17-beta-Phenylpropionyloxy-4-estren-3-one, 17beta-Phenylpropionyloxy-4-estrene-3-one, 17-beta-hydroxyestr-4-en-3-one hydrocinnamate, SCHEMBL8443, 3-Oxo-4-estren-17beta-yl-(3-phenylpropionat), 4-09-00-01758 (Beilstein Handbook Reference), orb1298695, orb3025293, 17-beta-Hydroxy-estra-4-en-3-one, 17-phenylpropionate, CHEMBL1200412, 17-beta-Hydroxyestr-4-en-3-one 17-(3-phenylpropionate), Estr-4-ene-3-one, 17-beta-hydroxy-, 3-phenylpropionate, MSK8505, Estr-4-en-3-one, hydrocinnamate, Estr-4-en-3-one, 17-(1-oxo-3-phenylpropoxy)-, (17beta)-, Tox21_113342, MSK8505-100A, MSK8505-100M, NANDROLONE PHENPROPIONATE CIII, NANDROLONE PHENPROPIONATE [MI], AKOS015888240, Tox21_113342_1, DB00984, DS-3294, FN26136, NANDROLONE PHENPROPIONATE [VANDF], NCGC00274069-01, NANDROLONE PHENPROPIONATE [WHO-DD], NANDROLONE PHENYLPROPIONATE [MART.], NS00006534, 17b-(3-Phenylpropionyloxy)-estr-4-en-3-one, C08155, D00956, H54922, NANDROLONE PHENPROPIONATE [ORANGE BOOK], NANDROLONE PHENPROPIONATE [USP IMPURITY], (17beta)-3-oxoestr-4-en-17-yl 3-phenylpropanoate, Estr-4-en-3-one, 17beta-hydroxy-, hydrocinnamate, Q4312826, (17b)-17-(1-Oxo-3-phenylpropoxy)-estr-4-en-3-one, ESTR-4-EN-3-ONE, 17-beta-HYDROXY-, HYDROCINNAMATE, Nandrolone phenylpropionate Solution in Methanol, 100ug/mL, 19-Nor-17b-hydroxy-3-ketoandrost-4-ene 1  7-phenylpropionate, Nandrolone phenylpropionate Solution in Acetonitrile, 100ug/mL, (8R,9S,10R,13S,14S,17S)-13-methyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl 3-phenylpropanoate
Theoretical properties:
molecular_formula: C27H34O3
molecular_weight: 406.6 g/mol
exact_mass: 406.25079494 g/mol
formal_charge: 0
hydrogen_bond_donor_count: 0
hydrogen_bond_acceptor_count: 3
rotatable_bond_count: 5
heavy_atom_count: 30
topological_polar_surface_area: 43.4 Å²
isotope_atom_count: 0
covalently_bonded_unit_count: 1
Physical properties:
Descriptions:
pubchem: Nandrolone phenpropionate is a 3-phenylpropionate ester. It has a role as an anabolic agent and an androgen. It is functionally related to a nandrolone.
chembl: NANDROLONE PHENPROPIONATE is a small molecule listed in the ChEMBL database and has reached clinical trial phase 4.0.
wikipedia: Nandrolone phenylpropionate (NPP), or nandrolone phenpropionate, sold under the brand name Durabolin among others, is an androgen and anabolic steroid (AAS) medication which has been used primarily in the treatment of breast cancer and osteoporosis in women. It is given by injection into muscle once every week. Although it was widely used in the past, the drug has mostly been discontinued and hence is now mostly no longer available.
Side effects of NPP include symptoms of masculinization like acne, increased hair growth, voice changes, and increased sexual desire. The drug is a synthetic androgen and anabolic steroid and hence is an agonist of the androgen receptor (AR), the biological target of androgens like testosterone and dihydrotestosterone (DHT). It has strong anabolic effects and weak androgenic effects, which give it a mild side effect profile and make it especially suitable for use in women and children. NPP is a nandrolone ester and a long-lasting prodrug of nandrolone in the body.
NPP was first described in 1957 and was introduced for medical use in 1959. It was the first nandrolone ester to be introduced, followed by nandrolone decanoate in 1962, and has been one of the most widely used nandrolone esters. However, in more recent times, the drug has been largely superseded by nandrolone decanoate, which is longer-acting and more convenient to use. In addition to its medical use, NPP is used to improve physique and performance. The drug is a controlled substance in many countries and so non-medical use is generally illicit.